Weekly reads: CRISPR sickle cell, Parkinson’s, pig-human chimera concerns
CRISPR gene editing has made rapid progress heading from bench to bedside. Perhaps the fastest has been its progress toward clinical use to combat sickle cell disease. We’ll start with a new paper on one major effort here. CRISPR gene editing. This process often involves cutting DNA, which then can be used as an opening to […]
Weekly reads: CRISPR sickle cell, Parkinson’s, pig-human chimera concerns Read More »